Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Chicken Monoclonal SREBF2 Primary Antibody for ELISA, GS - ABIN4355936
Janowski, Shan, Russell: The hypocholesterolemic agent LY295427 reverses suppression of sterol regulatory element-binding protein processing mediated by oxysterols. in The Journal of biological chemistry 2001
Show all 14 Pubmed References
Human Polyclonal SREBF2 Primary Antibody for ICC, IF - ABIN261631
Huster, Purnat, Burkhead, Ralle, Fiehn, Stuckert, Olson, Teupser, Lutsenko: High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease. in The Journal of biological chemistry 2007
Show all 6 Pubmed References
Human Monoclonal SREBF2 Primary Antibody for IP, WB - ABIN967564
Hua, Sakai, Ho, Goldstein, Brown: Hairpin orientation of sterol regulatory element-binding protein-2 in cell membranes as determined by protease protection. in The Journal of biological chemistry 1996
Show all 4 Pubmed References
Human Monoclonal SREBF2 Primary Antibody for ChIP, WB - ABIN2668815
Daniëls, Smans, Royaux, Chypre, Swinnen, Zaidi: Cancer cells differentially activate and thrive on de novo lipid synthesis pathways in a low-lipid environment. in PLoS ONE 2014
Show all 2 Pubmed References
Human Polyclonal SREBF2 Primary Antibody for IP, WB - ABIN4355938
Karanth, Tran, Kuberan, Schlegel: Polyunsaturated fatty acyl-coenzyme As are inhibitors of cholesterol biosynthesis in zebrafish and mice. in Disease models & mechanisms 2013
Data, including data from studies using transgenic mice, suggest that oligodendroglial myelination requires astrocyte-derived lipids; oligodendrocyte-specific inactivation of sterol regulatory element-binding protein (SREBP) cleavage-activating protein (SCAP), an essential factor in lipid biosynthesis along with SREBP2, results in significantly retarded CNS myelination.
The findings suggest that Cyp3a deficiency stimulated the expression of Scap via activation of the AR, which elevated cholesterogenic gene expression levels through activation of SREBP2 and increased total cholesterol contents in the prostate.
SIRT1 (show SIRT1 Antibodies) gene knock-out may aggravate cartilage degeneration in osteoarthritis by activating the SREBP2 protein-mediated PI3K/AKT (show AKT1 Antibodies) signalling pathway, suggesting that SIRT1 (show SIRT1 Antibodies) gene may play a protective role against osteoarthritis.
SREBP-2 is critical for survival and limb patterning during development
Identify a novel signaling pathway in hepatocytes triggered by ligand-activated p75NTR (show NGFR Antibodies) that via p38 MAPK (show MAPK14 Antibodies) and caspase-3 (show CASP3 Antibodies) mediate the activation of SREBP2. This pathway may regulate LDLRs and lipid uptake particularly after injury or during tissue inflammation accompanied by an increased production of growth factors, including NGF (show NGFB Antibodies) and pro-NGF (show NGFB Antibodies).
This study reveals SHP (show LAMC1 Antibodies) as a global transcriptional partner of SREBP-2 in regulation of sterol biosynthetic gene networks and provides a potential mechanism for cholesterol-lowering action of FGF19 (show FGF19 Antibodies).
activation of the sterol regulatory element binding protein-2 (SREBP2) was found to be downstream of ER stress, and this activation was affirmed to account for the intracellular accumulation of cholesterol using RNAi technique
ITCH modulates SIRT6 (show SIRT6 Antibodies) and SREBP2 to influence lipid metabolism and atherosclerosis in ApoE (show APOE Antibodies) null mice
SREBP2-induced miR (show MLXIP Antibodies)-92a targets key molecules in endothelial homeostasis, including sirtuin 1 (show SIRT1 Antibodies), Kruppel-like factor 2, and Kruppel-like factor 4 (show KLF4 Antibodies), leading to NOD-like receptor family pyrin domain-containing 3 inflammasome activation and endothelial nitric oxide synthase (show NOS3 Antibodies) inhibition.
The cholesterol-lowering effects of FGF21 (show FGF21 Antibodies) are abrogated by hepatic expression of sterol regulatory element-binding protein-2.
Date indicate that sterol regulatory element-binding proteins Srebp1 (show SREBF1 Antibodies) and Srebp2 are essential for the metabolic reprogramming of NK cells and for the attainment of elevated glycolysis and oxidative phosphorylation.
SREBP-1 (show SREBF1 Antibodies) and SREBP-2 mRNA expression levels were measured in EAT from 49 patients with CAD (show CAD Antibodies) (26 with diabetes) and 23 controls without CAD (show CAD Antibodies) or diabetes.SREBP expression was associated as cardiovascular risk factor for the severity of CAD (show CAD Antibodies) and the poor lipid control.
High expression of SREBF2 is associated with high carotid intima-media thickness.
mechanistic investigation provides clinical insights into protective roles of the epithelial cholesterol deficiency against excessive inflammatory responses via the SREBP2-HuR (show ELAVL1 Antibodies) circuit, although the deficiency triggers transient pro-inflammatory signals.
Dietary flavones counteract phorbol 12-myristate 13-acetate-induced SREBP-2 processing in hepatic cells.
Data show that mutant p53 protein (show TP53 Antibodies) activates the sterol regulatory element-binding proteins SREBP-1 (show SREBF1 Antibodies) and SREBP-2-mediated signaling pathways in prostate cancer (PCa (show FLVCR1 Antibodies)) cells.
The connections of EGFR (show EGFR Antibodies) and ERBB4 (show ERBB4 Antibodies) signaling with SREBP-2-regulated cholesterol metabolism are likely to be important in ERBB (show EGFR Antibodies)-regulated developmental processes and may contribute to metabolic remodeling in ERBB (show EGFR Antibodies)-driven cancers.
Akt1 (show AKT1 Antibodies) and Akt2 (show AKT2 Antibodies) activated both SREBP-1 (show SREBF1 Antibodies) and SREBP-2, whereas Akt3 (show AKT3 Antibodies) upregulated SREBP-1 (show SREBF1 Antibodies) to enhance hepatitis C virus translation.
knockdown of endogenous SREBP2 in HepG2 cells lowered ACSL1 (show Acsl1 Antibodies) mRNA and protein levels.
dysregulation of SIRT1 (show SIRT1 Antibodies)-AMPK (show PRKAA1 Antibodies)-SREBP and stimulation of NLRP3 (show NLRP3 Antibodies) inflammasome may contribute to vascular lipid deposition and inflammation in atherosclerosis
KLF13 (show KLF13 Antibodies) and SREBP-Sp1 (show SP1 Antibodies) activation interact to regulate low density lipoprotein receptor (show LDLR Antibodies) promoter function
This gene encodes a ubiquitously expressed transcription factor that controls cholesterol homeostasis by stimulating transcription of sterol-regulated genes. The encoded protein contains a basic helix-loop-helix-leucine zipper (bHLH-Zip) domain.
sterol regulatory element binding transcription factor 2
, sterol regulatory element-binding protein 2-like
, sterol regulatory element binding protein 2
, sterol regulatory element-binding protein 2
, sterol regulatory element-binding transcription factor 2
, class D basic helix-loop-helix protein 2
, sterol regulatory element binding factor 2